2026-04-17T03:45:06Zhttps://recercat.cat/oai/requestoai:recercat.cat:11351/107662025-10-24T10:41:48Zcom_2072_378070com_2072_378040col_2072_378092
RECERCAT
author
Villamarín Melio, Miguel
author
Len, Oscar
2025-10-24T10:41:48Z
2025-10-24T10:41:48Z
2024-01-08T10:43:27Z2024-01-08T10:43:27Z2023-11
http://hdl.handle.net/11351/10766
SARS-CoV-2 infection; Transplant recipients; Solid organInfecció per SARS-CoV-2; Receptors de trasplantament; Òrgans sòlidsInfección por SARS-CoV-2; Receptores de trasplantes; Órganos sólidosSolid organ transplant recipients (SOTR) constitute one of the groups at highest risk for the development of severe COVID-19. However, evidence on the effectiveness of treatments for SARS-CoV-2 infection in this group of patients is scarce. Molnupiravir is an orally administered antiviral drug that has demonstrated effectiveness in reducing the risk of progression to severe COVID-19 in high-risk outpatients, mainly in the unvaccinated population. Although its effectiveness is lower than that of other antivirals, on many occasions it is the only therapeutic option in transplant recipients given the absence of pharmacological interactions with immunosuppressive treatment, the oral route of administration and the good safety profile.
Attribution-NonCommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0/ info:eu-repo/semantics/openAccess
COVID-19 (Malaltia)
Trasplantació d'òrgans, teixits, etc.
DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections
NAMED GROUPS::Persons::Transplant Recipients
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Surgical Procedures, Operative::Transplantation::Organ Transplantation
ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus
DENOMINACIONES DE GRUPOS::personas::receptores de trasplantes
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::intervenciones quirúrgicas::trasplante::trasplante de órganos
SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion